New: Biosimilars strategies introduced.
Close
Valuable and timely information on drug therapy issues impacting today's health care and pharmacy environment.
June 20, 2024 - Botanix announced the FDA approval of Sofdra (sofpironium), treatment of primary axillary hyperhidrosis in adults and pediatric patients 9 years of age and older.
Download PDF
Return to publications
